BIOCON BIOLOGICS SPAIN S.L. secures contract for Pharmaceutical products - Supply of intravenous Trastuzumab (DOE), Mycophenolate Mofetil (DOE), Mycophenolic Acid (DOE), Dexmedetomidine (DOE) and Aztreonam (DOE)

Posted On: 2026-08-14

Spain, Aug. 14 -- Spain based BIOCON BIOLOGICS SPAIN S.L. has secured contract from Organo Administrativo de Recursos Contractuales de la Comunidad Autonoma de Euskadi for Pharmaceutical products - Supply of intravenous Trastuzumab (DOE), Mycophenolate Mofetil (DOE), Mycophenolic Acid (DOE), Dexmedetomidine (DOE) and Aztreonam (DOE) . The value of the contract is worth 448000 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

BIOCON BIOLOGICS SPAIN S.L. secures contract for Pharmaceutical products - Supply of intravenous Trastuzumab (DOE), Mycophenolate Mofetil (DOE), Mycophenolic Acid (DOE), Dexmedetomidine (DOE) and Aztreonam (DOE)